therapeutic 2,405 words KG: ent-gene-9f063e98 2026-03-26
kind:therapeuticsection:therapeuticsstate:published
Contents

LRRK2 Kinase-Targeting Therapies

🔬 Protein Info
Gene Symbolent-gene-9f063e98
Armadillo repeatsProtein-protein interactions
Ankyrin repeatsProtein-protein interactions
Leucine-rich repeat (LRR)Substrate recognition
ROC GTPase domainGTP binding/hydrolysis
COR domainInterdomain regulation
Kinase domainCatalytic (ATP binding)
WD40 repeatsProtein interactions
CompoundCompany
BIIB122 (DNL151)Biogen/Denali
DNL201Denali
MLK-1468Merck
DNL151Denali
ApproachTarget
LRRK2 ASOsLRRK2 mRNA
Allele-selective ASOsMutant allele
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.46
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.68
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.55
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.57

Related Analyses (16)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (30)

LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

See Also (15)

Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 4 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 4 hypotheses

Knowledge Graph (2 edges)

ent-gene-9f063e98 data_in benchmark_ot_ad_answer_key:LRRK2
benchmark_ot_ad_answer_key:LRRK2 data_in ent-gene-9f063e98